You can now download his presentation slides and video from the event, where he addresses how a winning assay development strategy is critical to ensure successful scale-up manufacturing.
Dr. Russell Marians joined LABS, Inc. as a Senior Scientist in 2010 and was promoted to Manager of Molecular and Cellular Biology in 2012. He also serves on the Scientific and Technical Advisory Committee of the American Association of Tissue Banks.
During his presentation, Dr. Marians focused on:
- Why robust assays are needed for manufacturing
- When to start developing assays
- Need a team approach to assay design to ensure success
Previously, Dr. Marians conducted biotech research at Taligen Therapeutics. His work on developing key PK/PD assays for preclinical studies, manufacturing processes development, production clone selection and target validation was instrumental in the sale of Taligen to Alexion Pharmaceuticals for $111 million. Dr. Marians received his PhD from the Mount Sinai Graduate School of Biological Sciences in 2001, and was a post-doctoral fellow at the University of Colorado.
LABS, Inc. is a comprehensive, highly accredited clinical reference testing laboratory serving the transplantation community. Their customers vary widely and include Organ Procurement Organizations, Reproductive Health and Transplant Centers, Tissue, Eye and Blood Banks, and Biomedical and Regenerative Medicine product manufacturers.
This year’s event will take place September 15-16 in Boston, MA. We hope to see you there!